Comparing telehealth strategies for lung cancer screening decision making
Pragmatic Trial
This study is looking at different ways to use telehealth to help lung cancer patients make better decisions about screening, so they can understand the risks and benefits more clearly and feel more comfortable participating, especially during the COVID-19 pandemic.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10898703 on NIH RePORTER |
What this research studies
This research investigates how different telehealth approaches can improve shared decision making for lung cancer screening among patients. It focuses on comparing four adaptive telehealth strategies to see which is most effective in helping patients understand the risks and benefits of screening. The study aims to address low participation rates in screening by making the decision-making process more accessible and informed, especially in the context of the COVID-19 pandemic. By using a Sequential Multiple Assignment Randomized Trial (SMART) design, the research will gather data on patient preferences and outcomes to enhance future telehealth practices.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are eligible for lung cancer screening, particularly those from diverse racial backgrounds.
Not a fit: Patients who are not eligible for lung cancer screening or those who have already undergone the necessary decision-making process may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved patient engagement and increased rates of lung cancer screening, ultimately reducing mortality from the disease.
How similar studies have performed: Other research has shown promise in using telehealth strategies to enhance patient decision-making, but this specific approach is novel and rigorously tested in real-world settings.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Rendle, Katharine a. — University of Pennsylvania
- Study coordinator: Rendle, Katharine a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.